(Q43779868)

26 November 2017

title

IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo (English)

1 reference

26 November 2017

1 reference

Jing Yang

1

1 reference

26 November 2017

Takayuki Ikezoe

2

1 reference

26 November 2017

Chie Nishioka

3

1 reference

26 November 2017

Atsuya Nobumoto

4

1 reference

26 November 2017

Akihito Yokoyama

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

6 May 2013

1 reference

International Journal of Cancer

26 November 2017

published in

1 reference

26 November 2017

volume

133

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

1967-1981

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

26 November 2017

cites work

1 reference

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

21 January 2018

1 reference

Anthracycline dose intensification in acute myeloid leukemia

21 January 2018

1 reference

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

21 January 2018

1 reference

21 January 2018

The Janus kinases (Jaks)

1 reference

Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents.

21 January 2018

1 reference

Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia.

21 January 2018

1 reference

Differential induction of IL-1beta and TNF by CD40 ligand or cellular contact with stimulated T cells depends on the maturation stage of human monocytes

21 January 2018

1 reference

Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism

21 January 2018

1 reference

Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene

21 January 2018

1 reference

CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells

21 January 2018

1 reference

Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells

21 January 2018

1 reference

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling

21 January 2018

1 reference

Self-renewal of leukemia stem cells in Friend virus-induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling but not mutation of p53.

21 January 2018

1 reference

Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways

21 January 2018

1 reference

DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes

21 January 2018

1 reference

Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains

21 January 2018

1 reference

TET family proteins and their role in stem cell differentiation and transformation.

21 January 2018

1 reference

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

21 January 2018

1 reference

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein

21 January 2018

1 reference

The Polycomb group protein EZH2 directly controls DNA methylation

21 January 2018

1 reference

The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity

21 January 2018

1 reference

Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia.

21 January 2018

1 reference

A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.

21 January 2018

1 reference

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

21 January 2018

1 reference

Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28198

1 reference

release_jlhn7ncqh5atjmrghw42f6qmci

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlhn7ncqh5atjmrghw42f6qmci

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference